Debra Odink
2010
In 2010, Debra Odink earned a total compensation of $446.2K as Chief Technology Officer, Pharmaceutical Research and Development at Anthera Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $80,000 |
|---|---|
| Salary | $232,179 |
| Stock Awards | $134,000 |
| Total | $446,179 |
Odink received $232.2K in salary, accounting for 52% of the total pay in 2010.
Odink also received $80K in non-equity incentive plan and $134K in stock awards.
Rankings
In 2010, Debra Odink's compensation ranked 8,100th out of 10,439 executives tracked by ExecPay. In other words, Odink earned more than 22.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,100 out of 10,439 | 22nd |
Division Manufacturing | 3,009 out of 3,838 | 22nd |
Major group Chemicals And Allied Products | 723 out of 926 | 22nd |
Industry group Drugs | 508 out of 685 | 26th |
Industry Pharmaceutical Preparations | 376 out of 481 | 22nd |
Source: SEC filing on April 5, 2013.
Odink's colleagues
We found four more compensation records of executives who worked with Debra Odink at Anthera Pharmaceuticals in 2010.